Author
PARAMITHIOTIS, E. - CAPRION PHARMACEUTICALS | |
PINARD, M. - CAPRION PHARMACEUTICALS | |
LAWTON, T. - IDEXX LABORATORIES | |
LABOISSIERE, S. - CAPRION PHARMACEUTICALS | |
LEATHERS, S. - IDEXX LABORATORIES | |
ZOU, WQ - UNIVERSITY OF TORONTO | |
ESTEY, L. - IDEXX LABORATORIES | |
LAMONTAGNE, J. - CAPRION PHARMACEUTICALS | |
LEHTO, M. - UNIVERSITY OF TORONTO | |
KONDEJEWSKI, L. - CAPRION PHARMACEUTICALS | |
FRANCOEUR, G. - IDEXX LABORATORIES | |
PAPADOPOULOS, M. - CAPRION PHARMACEUTICALS | |
HAGHIGHAT, A. - CAPRION PHARMACEUTICALS | |
SPATZ, S. - IDEXX LABORATORIES | |
HEAD, M. - NATIONAL CREUTZFELDT-JACO | |
WILL, R. - NATIONAL CREUTZFELDT-JACO | |
IRONSIDE, J. - NATIONAL CREUTZFELDT-JACO | |
O'Rourke, Katherine | |
TONELLI, Q. - IDEXX LABORATORIES | |
LEDEBUR, H. - CAPRION PHARMACEUTICALS | |
CHAKRABARTTY, A. - UNIVERSITY OF TORONTO | |
CASHMAN, N. - CAPRION PHARMACEUTICALS |
Submitted to: Nature Medicine
Publication Type: Peer Reviewed Journal Publication Acceptance Date: 5/20/2003 Publication Date: 7/1/2003 Citation: Paramithiotis, E., Pinard, M., Lawton, T., Laboissiere, S., Leathers, S., Zou, W., Estey, L., Lamontagne, J., Lehto, M.T., Kondejewski, L.H., Francoeur, G.P., Papadopoulos, M., Haghighat, A., Spatz, S.J., Head, M., Will, R., Ironside, J., Orourke, K.I., Tonelli, Q., Ledebur, H.C., Chakrabartty, A., Cashman, N.R. 2003. A prion protein epitope selective for the pathologically misfolded conformation. Nature Medicine. 9(7):893-899. Interpretive Summary: Diagnosis of the transmissible spongiform encephalopathies is based on detection of an abnormal, disease-associated form of a normal protein found in cattle, sheep, and humans. The normal and the abnormal protein share many structural features and most antibodies are unable to distinguish between the forms without extensive treatment of the tissue with enzymes, heat, or acid. The authors describe a method for detecting an area of the protein that changes shape during the shift from the normal to the abnormal form. Using this antibody, they could detect the abnormal form in tissues from mice and sheep without the use of these time-consuming treatment steps. This approach may lead to improved diagnostics and therapeutics for this group of diseases. Technical Abstract: The transmissible spongiform encephalopathies (prion diseases) are characterized by accumulation of an abnormal isoform of the normal mammalian sialoglycoprotein PrP. The normal and the abnormal isoforms have the same primary structure and conventional antibodies raised to recombinant or synthetic peptides typically fail to distinguish between the forms. The authors describe a technique for identifying epitopes on the surface of the folded protein after conversion to the beta-sheet rich abnormal conformation. An antibody to this epitope could recognize the abnormal isoform in a number of test formats. Conformation-specific antibodies may lead to new diagnostic and therapeutic targets for prion diseases. |